Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Urothelial Carcinoma of the Bladder | Bladder (Urothelial, Transitional Cell) Cancer | Bladder Cancer Recurrence | Progression of Bladder Cancer | Transurethral Resection of Bladder Tumor

Low Grade Glioma (LGG) of Brain With BRAF Aberration | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Low Grade Glioma of Brain With Neurofibromatosis Type 1

Stomach Cancer | Breast Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Endometrial Cancer | Liver Cancer

Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma

Recurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free Margins

Melanoma (Skin) | Basal Cell Carcinoma | Squamous Cell Carcinoma in Situ | Ocular Tumor | Melanoma in Situ | Nevus Eye | Sebaceous Gland Carcinoma of the Eyelid

Renal Cell Carcinoma | Mesothelioma, Malignant | Adenocarcinoma of Lung | Triple Negative Breast Cancer | Endometrial Cancer | Fallopian Tube Carcinoma | Peritoneal Carcinoma | Leiomyosarcoma | Liposarcoma | Ovarian Carcinoma

Participants Must be Women Aged 25 Years or Older | Participants Should Have no Self-reported History of Heart Disease or Stroke | Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease | Participants Should Not be a Healthcare Professionals or Healthcare Trainees | Participants Should Not be Employed in the Healthcare Field | Participants Should Reside in the United States and be a University of California, San Francisco Health Patient | Participants Should Possess a Smartphone With an Active Data Plan or Access to Wi-Fi

Multiple Sclerosis | Amyotrophic Lateral Sclerosis | Frontotemporal Dementia

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Unresectable Gastroesophageal Junction Adenocarcinoma | Metastatic Malignant Neoplasm in the Brain | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

Gastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ Adenocarcinoma

Papillary Carcinoma of Thyroid Gland | Metastatic Medullary Thyroid Cancer | Follicular Thyroid Cancer Lymph Node Metastasis

Depressive Symptoms | Myasthenia Gravis | Mental Health | Mental Well-being | Activities of Daily Living | Emotional Regulation | Psychological Stress | Psychological Well-being | Quality of Life (QOL) | Well-Being, Psychological

Cervical Cancer | Cervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Human Papillomavirus Infection | Adenocarcinoma in Situ | Low-Grade Squamous Intraepithelial Lesions | High-Grade Squamous Intraepithelial Lesions | Cervical Intraepithelial Neoplasia Grade II | Cervical Intraepithelial Neoplasia, Grade III | Negative For Intraepithelial Lesion Or Malignancy

Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy

Soft Tissue Sarcoma | Small Cell Lung Cancer | Ovarian Cancer | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Gastric Carcinoma | Solid Tumors | Pancreatic Ductal Adenocarcinoma | Endometrial Carcinoma

Myasthenia Gravis | Myotonic Dystrophy | Inclusion Body Myositis | Facioscapulohumeral Muscular Dystrophies | The Falls Efficacy Scale International | The Morse Fall Scale

Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Tongue Cancer

Multiple Sclerosis | Fatigue | Fall | Gait Disorders, Neurologic | Kinematics | Physiotherapy | Postural Balance | Biomechanics | Kinetics | Motion Analysis

Transurethral Resection of the Prostate (TURP) | Detrusor Underactivity

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Relapsing-Remitting Multiple Sclerosis (RRMS) | Anti-CD20 Therapy

Multiple Sclerosis | Cognitive Impairment

Temporomandibular Disorders (TMD) | Anterior Disc Displacement | Internal Derangement of the Tempromandibular Joint

Multiple Sclerosis

Multiple Sclerosis

Optic Neuritis

Myasthenia Gravis

Neuromyelitis Optica Spectrum Disorder

Progressive Multiple Sclerosis | Multiple Sclerosis

Progressive Multiple Sclerosis

Primary Disease or Condition Being Studied, or Focus of the Study

Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorder

Myasthenia Gravis

Cancer of the Endometrium

Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Multiple Sclerosis

Prostate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate Cancer

Aicardi-Goutières Syndrome (AGS)

Neuromyelitis Optica Spectrum Disorder

Vitamin d Deficiency

Optic Neuromyelitis Spectrum Disease

Respiratory Failure | TTN | PPHN

Multiple Sclerosis | Relapsing-remitting Multiple Sclerosis

Relapsing-remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis

Neuromyelitis Optica Spectrum Disorder

Neuromyelitis Optica Spectrum Disorder | NMOSD

Progressive Multiple Sclerosis | Multiple Sclerosis